Cellnex says Poland deal cuts 2027 cash flow by €300 mln, Q3 in line

Cellnex said its roughly €500 million Polish investment will reduce 2027 free cash flow by about €300 million, while reiterating guidance; shares were little changed. Third-quarter revenue excluding pass-through was €1.01 billion versus €1.02 billion consensus, while adjusted EBITDA was €863 million versus €860 million expected. Nine-month free cash flow more than doubled to €474 million, and the company remained on track to return €1 billion to shareholders in 2026, with €924 million delivered by September 30.

Analysis

The key issue is cash-flow timing, not the stated project return. The Polish build-out may improve asset economics over time, but the roughly €300 million 2027 FCF drag makes near-term deleveraging and shareholder-return capacity more dependent on execution. With leverage still high, investors should distinguish recurring operating improvement from FCF supported by temporarily lower build-to-suit capex. The margin and cost trends are constructive, but they do not by themselves establish that incremental cash will arrive quickly enough to offset the project spend.

The market may be underweighting a guidance-definition risk: Cellnex reiterated its 2027 like-for-like FCF range while also describing a material project-related reduction. Verify whether the range includes the Polish investment and whether the impact is concentrated in 2027 or persists beyond it. The committed co-locations could create durable utilization, while relocations and decommissionings may improve asset efficiency; conversely, delivery delays, cost overruns, or Polkomtel concentration would weaken the return case. Tower peers such as American Tower and Vantage Towers could benefit if capital allocation shifts away from competing build-outs, though the effect is unlikely to be immediate.

Near term, broadly in-line results and stable shares argue against chasing an earnings trade. Over 1–3 months, focus on updated FCF phasing, capex, and leverage commentary. Over 6–18 months, the thesis turns on realized co-location economics and whether leverage reaches the stated range without compromising returns. The double-digit project return is management’s expectation, not independently verified evidence.

Key Decisions for Investors

• No immediate directional trade: wait for clarification on whether the 2027 FCF target includes the Polish investment and how much of the €300 million impact is timing versus lasting cash-flow dilution.
• Treat Cellnex as a conditional watch/underweight versus tower peers until project phasing and leverage progression are clearer; do not infer a valuation discount or peer mispricing without current multiples and FCF yields.
• Reassess after the next update on Polish capex, co-location delivery, and net leverage. The thesis weakens if costs or timing slip, committed deployments fail to materialize, or leverage progress stalls; it strengthens if cash returns are delivered while leverage continues to fall.